<DOC>
	<DOCNO>NCT02357797</DOCNO>
	<brief_summary>This 16-week , randomize , double-blind , parallel group , placebo-controlled study compare adjunctive vortioxetine identically appear adjunctive placebo pill 88 stable patient research diagnosis schizophrenia determine Structured Clinical Interview DSM ( SCID ) . Patient randomization stratify illness duration ( i.e. , &lt; /=5 year &gt; 5 year ) order allow post-hoc analysis examine whether early illness moderate great negative /or cognitive symptom reduction response vortioxetine .</brief_summary>
	<brief_title>Adjunctive Vortioxetine Schizophrenia</brief_title>
	<detailed_description>This 16-week , randomize , double-blind , parallel group , placebo-controlled study compare adjunctive vortioxetine identically appear adjunctive placebo pill 88 stable patient research diagnosis schizophrenia determine Structured Clinical Interview DSM ( SCID ) . Patient randomization stratify illness duration ( i.e. , &lt; /=5 year &gt; 5 year ) order allow post-hoc analysis examine whether early illness moderate great negative /or cognitive symptom reduction response vortioxetine . Patients clinical stability least 3 month stable antipsychotic psychotropic medication treatment least last 4 week without relevant depression , positive psychotic symptom extrapyramidal symptoms EPS eligible . After write informed consent , patient undergo screen visit confirm full study eligibility . If in- exclusion criterion fulfil , patient undergo baseline assessment randomize 1:1 16 week adjunctive treatment vortioxetine placebo . Subsequently , patient see week 1 , 2 , 4 monthly next 3 month .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>1 . Outpatient 2 . SCID diagnosis schizophrenia 3 . Age 1865 year old 4 . Treated adequate dose one maximum two antipsychotic medication least 3 month , stable dose least last 4 week , willing continue 16 week . 5 . No antidepressant treatment least 8 week prior randomization . 6 . Treatment concomitant , nonantipsychotic , psychiatric medication allow , must unchanged least 8 week , stable dose least last 4 week , willing continue 16 week . Benzodiazepines must give within 8 hour cognitive assessment . Treatment nonpsychiatric medication unrestricted . 7 . PANSS Negative subscore &gt; 14 least two item level &gt; /=4 ( moderate ) 8 . PANSS Positive subscore &lt; /=14 one item level &gt; /=4 ( moderate ) 9 . HAMD17 total score &lt; /=12 10 . Simpson Angus Score item &lt; 3 11 . Englishspeaking 12 . Competent willing sign inform consent 1 . Structural brain disease 2 . Mental retardation history estimate IQ &lt; 70 ( WRATIII Word Reading ) 3 . Autismspectrum disorder diagnosis history 4 . Any serious chronic medical illness view investigator interfere patient 's ability comply study procedure interfere cognition . 5 . Active substance abuse dependence past 8 week 6 . Intolerance inefficacy vortioxetine past 7 . Acute anger self others per investigator assessment 8 . Pregnant breastfeeding female 9 . Unwilling unable sexually abstinent use effective form birth control sexually active 10 . Current treatment Monoamine Oxidase Inhibitor ( MAOI )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>